HMG-CoA reductase inhibitors (statins) are common lipid-lowering drugs in clinical practice, which can effectively reduce LDL and cholesterol levels, and are widely used in the primary and secondary prevention of cardiovascular and cerebrovascular diseases based on atherosclerosis [33]. The gene discussed is HMGCR; the disease is cerebrovascular disorder.